NICOLE', Stefano
 Distribuzione geografica
Continente #
NA - Nord America 322
EU - Europa 264
AS - Asia 131
SA - Sud America 1
Totale 718
Nazione #
US - Stati Uniti d'America 320
CN - Cina 109
GB - Regno Unito 83
SE - Svezia 32
IT - Italia 29
FR - Francia 28
IE - Irlanda 22
DE - Germania 19
FI - Finlandia 19
RU - Federazione Russa 18
SG - Singapore 9
UA - Ucraina 8
KR - Corea 5
JP - Giappone 4
BE - Belgio 2
CA - Canada 2
CZ - Repubblica Ceca 2
IN - India 2
TR - Turchia 2
BG - Bulgaria 1
CL - Cile 1
RO - Romania 1
Totale 718
Città #
Southend 80
Chandler 79
Ann Arbor 34
Woodbridge 32
Ashburn 27
Beijing 25
Jacksonville 24
Dublin 22
Helsinki 13
Shenyang 13
Lawrence 11
Princeton 11
Jinan 10
Wilmington 9
Hebei 8
Nanjing 8
Verona 6
Seoul 5
Tianjin 5
Ningbo 4
Singapore 4
Bologna 3
Giussano 3
Haikou 3
Hangzhou 3
Houston 3
Taiyuan 3
Taizhou 3
Tokyo 3
Brno 2
Brussels 2
Changsha 2
Clearwater 2
Fuzhou 2
Lanzhou 2
Montréal 2
New York 2
Boardman 1
Dallas 1
Düsseldorf 1
Esslingen am Neckar 1
Fairfield 1
Guangzhou 1
Jiaxing 1
Lancaster 1
Munich 1
Nanchang 1
Nashville 1
Redmond 1
Rieti 1
Riva 1
San Diego 1
Seattle 1
Secunderabad 1
Shenzhen 1
Sindelfingen 1
Torino 1
Villaricca 1
Washington 1
Xiangfen 1
Zhengzhou 1
Totale 494
Nome #
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 93
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 88
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 77
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 77
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 75
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 68
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 62
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 54
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 54
VIROLOGICAL EFFICACY OF A REDUCED DOSE OF NEVIRAPINE IN A SMALL COHORT OF SUPPRESSED HIV-1-INFECTED PATIENTS 50
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 49
Totale 747
Categoria #
all - tutte 2.680
article - articoli 2.680
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.360


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202065 0 2 2 1 13 9 4 2 1 4 11 16
2020/202185 11 14 3 15 11 7 3 0 3 9 8 1
2021/202283 7 35 1 5 0 0 1 9 2 2 2 19
2022/2023206 12 29 16 41 15 47 1 13 26 0 2 4
2023/2024104 3 9 11 10 12 20 0 13 1 6 9 10
2024/202520 9 11 0 0 0 0 0 0 0 0 0 0
Totale 747